Spironolactone and low-dose dexamethasone enhance extinction of contextual fear conditioning

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 7, 2010, Pages 1229-1235

  Ninomiya, Ester Mayumi ^a   Martynhak, Bruno Jacson ^a   Zanoveli, Janaina M ^a   Correia, Diego ^a   da Cunha, Cláudio ^a   Andreatini, Roberto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Contextual fear memory; Glucocorticoid receptor; Mineralocorticoid receptor; PTSD

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; FLUDROCORTISONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; PROPRANOLOL; SPIRONOLACTONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEAR; FUNCTION TEST; LEARNING; LOW DRUG DOSE; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL FUNCTION; NONHUMAN; RAT; STIMULUS RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEAR; GLUCOCORTICOIDS; MALE; MAZE LEARNING; PROPRANOLOL; RATS; RATS, WISTAR; SPIRONOLACTONE;

EID: 77956428423     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.06.025     Document Type: Article

References (56)

1. Abrari K., Rashidy-Pour A., Semnanian S., Fathollahi Y. Administration of corticosterone after memory reactivation disrupts subsequent retrieval of a contextual conditioned fear memory: Dependence upon training intensity. Neurobiol Learn Mem 2008, 89:178-184.
2. Adamec R., Muir C., Grimes M., Pearcey K. Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress. Behav Brain Res 2007, 179:192-207.
3. Aerni A., Traber R., Hock C., Roozendaal B., Schelling G., Papassotiropoulos A., et al. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 2004, 161:1488-1490.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders, 4th edition, text revision 2000, American Psychiatric Press, Washington DC.
5. Atkinson H.C., Wood S.A., Castrique E.S., Kershaw Y.M., Wiles C.C., Lightman S.L. Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor. Am J Physiol Endocrinol Metab 2008, 294:E1011-E1022.
6. Berger S., Wolfer D.P., Selbach O., Alter H., Erdmann G., Reichardt H.M., et al. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci USA 2006, 103:195-200.
7. Bitran D., Shiekh M., Dowd J.A., Dugan M.M., Renda P. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors. Pharmacol Biochem Behav 1998, 60:879-887.
8. Blanchard R.J., Blanchard C. Crouching as an index of fear. J Comp Physiol Psychol 1969, 67:370-375.
9. Bohus B., De Kloet E.R. Adrenal steroids and extinction behavior: antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone. Life Sci 1981, 28:433-440.
10. Brinks V., Berger S., Gass P., de Kloet E.R., Oitzl M.S. Mineralocorticoid receptors in control of emotional arousal and fear memory. Horm Behav 2009, 56:232-238.
11. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol 2006, 147(Suppl 1):S258-S268.
12. Cai W.H., Blundell J., Han J., Greene R.W., Powell C.M. Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci 2006, 26:9560-9566.
13. Calvo N., Volosin M. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 2001, 73:261-271.
14. Cammarota M., Bevilaqua L.R., Vianna M.R., Medina J.H., Izquierdo I. The extinction of conditioned fear: structural and molecular basis and therapeutic use. Rev Bras Psiquiatr 2007, 29:80-85.
15. Cordero M.I., Sandi C. A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity. Brain Res 1998, 786:11-17.
16. de Gasparo M., Joss U., Ramjoué H.P., Whitebread S.E., Haenni H., Schenkel L., et al. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J Pharmacol Exp Ther 1987, 240:650-656.
17. De Kloet E.R., De Jong I.E.M., Oitzl M.S. Neuropharmacology of glucocorticoids: focus on emotion, cognition and cocaine. Eur J Pharmacol 2008, 585:473-482.
18. De Quervain D.J.F., Margraf J. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur J Pharmacol 2008, 583:365-371.
19. De Quervain D.J.F., Roozendaal B., McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998, 394:787-790.
20. Do Monte F.H.M., Canteras N.S., Fernandes D., Assreuy J., Carobrez A.P. New perspectives on β-adrenergic mediation of innate and learned fear responses to predator odor. J Neurosci 2008, 28:13296-13302.
21. Donley M.P., Schulkin J., Rosen J.B. Glucocorticoid receptor antagonism in the basolateral amygdala and ventral hippocampus interferes with long-term memory of contextual fear. Behav Brain Res 2005, 164:197-205.
22. Douma B.R., Korte S.M., Buwalda B., la Fleur S.E., Bohus B., Luiten P.G. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology 1998, 23:33-44.
23. Hlavacova N., Jezova D. Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats. Endocr Regul 2008, 42:147-153.
24. Hlavacova N., Bakos J., Jezova D. Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. J Psychopharmacol 2010, 24:779-786.
25. Joëls M., Karst H., De Rijk R., De Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci 2008, 31:1-7.
26. Juruena M.F., Cleare A.J., Pariante C.M. The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr 2004, 26:189-201.
27. Juruena M.F., Gama C.S., Berk M., Belmonte-de-Abreu P.S. Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series. J Psychopharmacol 2009, 23:985-987.
28. Kammerl M.C., Richthammer W., Kurtz A., Krämer B.K. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol 2002, 282:R1613-R1617.
29. Kellner M., Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol 2008, 583:372-378.
30. Kellner M., Baker D.G., Yassouridis A., Bettinger S., Otte C., Naber D., et al. Mineralocorticoid receptor function in patients with posttraumatic stress disorder. Am J Psychiatry 2002, 159:1938-1940.
31. Khaksari M., Rashidy-Pour A., Vafaei A.A. Central mineralocorticoid receptors are indispensable for corticosterone-induced impairment of memory retrieval in rats. Neuroscience 2007, 149:729-738.
32. Korte S.M., de Boer S.F., de Kloet E.R., Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995, 20:385-394.
33. Korte S.M., Korte-Bouws G.A.H., Koob G.F., De Kloet E.R., Bohus B. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. Pharmacol Biochem Behav 1996, 54:261-267.
34. Kroon J.A.V., Carobrez A.P. Olfactory fear conditioning paradigm in rats: effects of midazolam, propranolol or scopolamine. Neurobiol Learn Mem 2009, 91:32-40.
35. Oitzl M.S., De Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 1992, 106:62-71.
36. Oitzl M.S., Champagne D.L., van der Veen R., de Kloet E.R. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 2010, 34:853-866.
37. Otte C., Muhtz C., Daneshkhah S., Yassouridis A., Kiefer F., Wiedemann K., et al. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone. Biol Psychiatry 2006, 60:784-787.
38. Otte C., Hinkelmann K., Moritz S., Yassouridis A., Jahn H., Wiedemann K., et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res 2010, 44:339-346.
39. Pamplona F.A., Prediger R.D.S., Pandolfo P., Takahashi R.N. The cannabinoid receptor agonist WIN 55, 212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology 2006, 188:641-649.
40. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985, 14:149-167.
41. Pitman R.K., Sanders K.M., Zusman R.M., Healy A.R., Cheema F., Laski N.B., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002, 51:189-192.
42. Prager E.M., Johnson L.R. Stress at the synapse: signal transduction mechanisms of adrenal steroids at neuronal membranes. Sci Signal 2009, 2. re5.
43. Pugh C.R., Fleshner M., Rudy J.W. Type II glucocorticoid receptor antagonists impair contextual but not auditory-cue fear conditioning in juvenile rats. Neurobiol Learn Mem 1997, 67:75-79.
44. Quirarte G.L., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 1997, 94:14048-14053.
45. Roozendaal B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002, 78:578-595.
46. Roozendaal B., Okuda S., De Quervain D.J.F., McGaugh J.L. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 2006, 138:901-910.
47. Smythe J.W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol Biochem Behav 1997, 56:507-513.
48. Taubenfeld S.M., Riceberg J.S., New A.S., Alberini C.M. Preclinical assessment for selectively disrupting a traumatic memory via postretrieval inhibition of glucocorticoid receptors. Biol Psychiatry 2009, 65:249-257.
49. Thompson B.L., Erickson K., Schulkin J., Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res 2003, 149:209-215.
50. Tronel S., Alberini C.M. Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala. Biol Psychiatry 2007, 62:33-39.
51. Vaiva G., Ducrocq F., Jezequel K., Averland B., Lestavel P., Brunet A., et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 2003, 54:947-949. [erratum 54:1471].
52. Van Praag H.M. The cognitive paradox in posttraumatic stress disorder: a hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:923-935.
53. Wu H.B.K., Niyomchai T., Festa E., Minerly A.E., Weierstall K., Hunter D., et al. Effects of RU 486 and tamoxifen on cocaine-induced behavioral and endocrinologic activations in male and female Fischer rats. Ethn Dis 2008, 18(2 Suppl 2). S2-81-6.
54. Yang Y.L., Chao P.K., Lu K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 2006, 31:912-914.
55. Yaniv D., Desmedt A., Jaffard R., Richter-Levin G. The amygdala and appraisal processes: stimulus and response complexity as an organizing factor. Brain Res Brain Res Rev 2004, 44:179-186.
56. Zhang L., Zhou R., Li X., Ursano R.J., Li H. Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med Hypotheses 2006, 66:1205-1208.